Trade Summary

3 days ago, Porter Derrell, serving as Dir at Acumen Pharmaceuticals, Inc. (ABOS), sold 32,300 shares at $2.33 per share, for a total transaction value of $75,239.50. Following this transaction, Porter Derrell now holds 35,500 shares of ABOS.

This sale represents a 47.64% decrease in Porter Derrell's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 5:10 PM ET, 2 days after the trade was made.

Acumen Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.